FDA approves use of Covidien's low-enriched uranium-derived Mo-99
This article was originally published in Clinica
Executive Summary
The US FDA has approved the use of molybdenum-99 (Mo-99) produced by Dublin, Ireland-based Covidien and derived from low-enriched uranium (LEU) in the production of technetium-99m (Tc-99m) generators.